Manufacturer record
CMG Biotech Pvt. Ltd.58: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
2 batches manufactured by CMG Biotech Pvt. Ltd.58 (Himachal Pradesh) were declared Not of Standard Quality between March 2020 and July 2021. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
2 records linked to CMG Biotech Pvt. Ltd.58 in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Enalapril Maleate Tablets IP (GNAP-2.5 TABLETS) | CT-201041Mfg 2020-12 · Exp 2022-11 | AssayAssay | RDTL ChandigarhState lab | Jul 2021 |
| Tamsulosin Hydrochloride Modified Release Capsule (GOTAM-0.4 CAPSULES) | CC-190002Mfg 2019-01 · Exp 2020-12 | DissolutionDissolution | RDTL ChandigarhCDSCO lab | Mar 2020 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.